Text Size

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France

Lazzaro C., Van Steen C., Aptel F., Schweitzer C., Angelillo L.


  • 2022
  • Journal of Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Affiliations

    Studio di Economia Sanitaria, Milan, Italy; Santen GmbH, München, Germany; Department of Ophthalmology, University Hospital, CHU Grenoble-Alpes, Grenoble, France; CHU Bordeaux, Department of Ophthalmology, University of Bordeaux, Bordeaux, 33000, France; Inserm, Bordeaux Population Health Research Center, Team LEHA, UMR 1219, Bordeaux, 33000, France

Related Publications

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost

Oddone F, Tanga L, Giammaria S, Sabbatini L, Strianese A, Ferrazza M, Rossetti LM


MicroRNA profile of extracellular vesicles released by Müller glial cells

Lamb W D.B.; Eastlake K.; Luis J.; Sharif N.A. ; Khaw P. T.; Limb G. A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022